Biophotonics; Plays an Important Role in the Development of Novel Healthcare Tools

 

Biophotonics
Biophotonics

Biophotonics is a combination of four technologies, such as photonics, nanotechnology, lasers, and biotechnology. Biophotonics is the science of producing and utilizing photons or light to image, identify, and engineer biological materials. A particularly important aspect of this field is imaging and sensing cells and tissue. Over the years, biophotonic technologies have received more & more attention, as more cost-saving, effective methods with applications ranging from medicine to life sciences research and beyond.

Global Biophotonics Market was valued at US$ 49.0 billion in 2018 and is predicted to reach US$ 95.0 billion, growing at a CAGR of 8.3% during the forecast period (2019 to 2027).

Biophotonics is the study of optical processes in biological systems, those that occur naturally and in bioengineered materials. Biophotonics research focuses on the development of optical imaging and sensing technologies to study biomolecule, cell, and tissue structure and function at nanoscopic and microscopic scales. This in turn help surgeons to see how the cells and tissues are working. This light technique provides sample of diseased and healthy tissue for diagnosis, treatment, and during surgery.

Using multiband photonic and spectroscopic methods it is able to analyze cells and tissues by the way these living structures absorb, reflect and scatter light. This can be used to diagnose and treat diseases ranging from cancer to strokes and Alzheimer's. Biophotonics uses photons to interrogate cancer microenvironments and eliminate cancer-based cells and tissues, and has paved new pathways for cancer research. Biophotonic imaging is emerging as a tool for clinical assessment of cancer at the microscopic and macroscopic scale.

According to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S. This in turn will increase the use of biophotonic imaging in the U.S., as there has been growing interest in the use of biophotonics and imaging for cancer screening and diagnosis and also for monitoring of treatment response. Biophotonics offer enhanced treatment solutions for critical diseases. Thus, with the increasing application of biophotonics-based treatment solutions, the use of biophotonic technologies is also increasing with the rapid pace.

Comments

Post a Comment

Popular posts from this blog

Recycled Construction Aggregates Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Image
  Recycled Construction Aggregates Market Introduction: The Recycled Construction Aggregates Market has gained significant traction in recent years, driven by increasing environmental concerns, resource scarcity, and the growing emphasis on sustainable construction practices. Recycled construction aggregates, derived from the processing and recycling of construction and demolition waste materials, offer several benefits such as reduced demand for virgin materials, decreased landfill waste, and lower carbon footprint. The market for recycled construction aggregates is expected to witness substantial growth and present lucrative opportunities for market players. Market Size and Share: The global recycled construction aggregates market is projected to surpass  6.2 million tons  by the end of 2027 in terms of volume, exhibiting a CAGR of  6.0%  during the forecast period  (2020 to 2027) . The market is driven by stringent environmental regulations, governmen...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more